MedPath

Nylia 1/35

Nylia 1/35 (Norethindrone and Ethinyl Estradiol Tablets, USP) 1 mg/0.035 mg Rx only

Approved
Approval ID

b31bd776-3926-4b77-aa29-f5a8eef611aa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 7, 2022

Manufacturers
FDA

Aurobindo Pharma Limited

DUNS: 650082092

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65862-898
Application NumberANDA207056
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone and Ethinyl Estradiol
Product Specifications
Effective DateSeptember 7, 2022
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nylia 1/35 - FDA Drug Approval Details